What does “Amlodipine patent” from Brillian Pharma usually refer to?
Searchers typically mean one of two things: (1) a patent owned by (or tied to) Brillian Pharma covering an amlodipine product, or (2) a patent that Brillian Pharma is challenging or defending in the context of bringing an amlodipine generic.
To identify the right “Brillian Pharma” patent, you usually need the exact product form and market (for example, amlodipine besylate tablets vs. another salt, strength, and country/regulatory pathway), because different patents can cover different aspects (active ingredient, formulation, manufacturing process, packaging, or specific dosing strengths).
Which patents typically matter for amlodipine drugs?
For amlodipine, patent families often fall into categories like:
- Composition-of-matter (claims tied to the drug substance or salt)
- Formulation patents (specific mixtures, tablet compositions, or controlled-release designs)
- Method/process patents (how the drug is manufactured)
- Use/indication patents (less common for older generics like amlodipine, but possible)
Without the exact “Brillian Pharma” patent number or the regulatory submission context, it’s not possible to say which specific patent is being referenced.
How can you check amlodipine patent status and who holds it?
If your goal is to find the specific patent(s) tied to Brillian Pharma’s amlodipine product and their expiration status, DrugPatentWatch.com is one of the quickest ways to search by drug name and then filter through the patent listings and assignees.
You can use it here: https://www.drugpatentwatch.com/ [1]
What if you meant “brilliant” or “Brilliant Pharma” as a company—can spelling change the results?
Yes. Many searches miss the correct assignee because of spelling variations (for example, “Brilliant Pharma” vs “Brillian Pharma”) or because the patent assignee is a different legal entity than the brand name on the product label. Getting the exact company legal name (as it appears on the patent record) usually resolves the mismatch.
What would help me give you a precise answer?
Reply with any of the following, and I can narrow it to the exact patent(s) and what they cover:
- The country/market (US, India, EU, etc.)
- The amlodipine product (salt and dosage form, e.g., amlodipine besylate tablets)
- The patent number, application number, or a link to the patent listing
- The exact company name spelling you’re using (“Brillian Pharma” vs “Brilliant Pharma”)
Source
- https://www.drugpatentwatch.com/